Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
AVNI Arvana Inc
ARCC Ares Capital Corp
BCDA BioCardia Inc
AFG American Financial Group Inc
MGEN miRagen Therapeutics Inc
CVLG Covenant Logistics Group Inc
ARLO Arlo Technologies Inc
BAC Bank of America Corp
PWOD Penns Woods Bancorp Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Price
Delayed
$81.38
Day's Change
0.99 (1.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
82.46
Day's Low
80.82
Volume
(Average)

Today's volume of 6,817,249 shares is on pace to be in-line with MRK's 10-day average volume of 8,740,996 shares.

6,817,249

Display:

Providers:

UpdateCancel
4 providers
Today's News, December 01, 2020
Merck stock price target raised to $98 from $92 at UBS

(END) Dow Jones Newswires December 01, 2020 11:26 ET (16:26 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

November 23, 2020
Merck to pay $425 million upfront to buy COVID-19 treatment developer OncoImmune

Shares of Merck & Co. Inc. (MRK) surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmune shareholders will...(MarketWatch)

Merch to buy biotech OncoImmune for $425 mln in cash upfront

(END) Dow Jones Newswires November 23, 2020 06:47 ET (11:47 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

November 10, 2020
Merck started at outperform with $95 stock price target at Bernstein

(END) Dow Jones Newswires November 10, 2020 14:36 ET (19:36 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

November 05, 2020
Merck to buy VelosBio for $2.75 billion to bolster oncology pipeline

Shares of Merck & Co. Inc. (MRK) rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to close by the end of...(MarketWatch)

Merck to buy VelosBio for $2.75 bln in cash

(END) Dow Jones Newswires November 05, 2020 06:33 ET (11:33 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

November 04, 2020
These stocks rose the most Wednesday as investors cheered a divided government following the elections

By Philip van Doorn, MarketWatch The Nasdaq Composite Index jumped 3.9%, led by tech and health-care stocks A contested presidential election has been considered a nightmare scenario by some members of the media, but investors seemed pleased...(MarketWatch)

Health care stocks soar, add more than 350 points to the Dow's price

Shares of UnitedHealth Group Inc. (UNH) soared 10.2% in morning trading, enough to pace the Dow Jones Industrial Average's gainers, as the uncertain election outcome is seen as a boon to the health care sector...(MarketWatch)

October 30, 2020
These are the worst-performing stocks in October as Big Tech slumps

By Philip van Doorn, MarketWatch The information technology sector fell over 5% for the month, the biggest drop for any industry October marked a cooling-off period for many large-cap technology stocks, which had led the market higher after...(MarketWatch)

October 28, 2020
Here are Wednesday's biggest losers in the stock market as 97% of S&P 500 companies dropped

By Philip van Doorn, MarketWatch Cruise lines took a beating as new coronavirus cases in the U.S. rose to a record Pre-election jitters and an elevated number of new COVID-19 infections helped send the S&P 500 Index of the largest U.S. stocks...(MarketWatch)

October 27, 2020
Merck raised 2020 adj. EPS outlook to $5.91-$6.01 from $5.63-$5.78

(END) Dow Jones Newswires October 27, 2020 06:51 ET (10:51 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

Merck Q3 sales $12.55 bln vs. $12.40 bln a year ago; FactSet consensus $12.21 bln

(END) Dow Jones Newswires October 27, 2020 06:49 ET (10:49 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

Merck Q3 EPS $1.16 vs. 74 cents a year ago

(END) Dow Jones Newswires October 27, 2020 06:49 ET (10:49 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

Merck Q3 adj. EPS $1.74; FactSet consensus $1.44

(END) Dow Jones Newswires October 27, 2020 06:49 ET (10:49 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

October 03, 2020
UPDATE: Here are the biggest winners in a solid third quarter for U.S. stocks

By Philip van Doorn, MarketWatch Gains were spread across tech, materials, industrials and retailers (Sept. 30 closing prices.) The third quarter shaped up to be favorable for U.S. stocks, with broad gains across many sectors, including...(MarketWatch)

September 25, 2020
UPDATE: Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine

By WILLIAM PETRI A top medical researcher explains how we would know if a vaccine is safe and effective With COVID-19 vaccines currently in the final phase of study, you've probably been wondering how the Food and Drug Administration will...(MarketWatch)

September 22, 2020
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine

By WILLIAM PETRI A top medical researcher explains how we would know if a vaccine is safe and effective With COVID-19 vaccines currently in the final phase of study, you've probably been wondering how the Food and Drug Administration will...(MarketWatch)

Vaccinex's stock falls after investigational drug fails Huntington's disease study

Shares of Vaccinex Inc. (VCNX) tumbled 61.6% in premarket trading on Tuesday after the preclinical biotechnology company said an experimental Huntington's disease treatment, pepinemab, did not meet the primary endpoints in a Phase 2 double-blind...(MarketWatch)

September 14, 2020
Shares of Seattle Genetics jump as Merck makes up to $4.2 billion investment

Shares of Seattle Genetics (SGEN) rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck & Co. Inc. (MRK). Shares of Merck were up 0.6%. The first deal allows Merck to co-develop and commercialize ladiratuzumab...(MarketWatch)

September 10, 2020
UPDATE: AstraZeneca's coronavirus vaccine setback shows why Big Pharma prefers to be safe than sorry. Which is good news

By Pierre Briançon AstraZeneca, the U.K.-based pharmaceuticals giant, said on Tuesday that it would pause the clinical trial of the coronavirus vaccine it is developing with the University of Oxford after a British subject became ill. The...(MarketWatch)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.